University of Texas MD Anderson Cancer Center (Site 102) — Hosuton, Texas

University of Texas MD Anderson Cancer Center (Site 102) is a clinical research site located in Hosuton, Texas, United States 77030.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas MD Anderson Cancer Center (Site 102) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Sponsors: J-Pharma Co., Ltd..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas MD Anderson Cancer Center (Site 102)?

University of Texas MD Anderson Cancer Center (Site 102) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas MD Anderson Cancer Center (Site 102) conducted?

University of Texas MD Anderson Cancer Center (Site 102) has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Is University of Texas MD Anderson Cancer Center (Site 102) accredited by Crixeo Health?

University of Texas MD Anderson Cancer Center (Site 102) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas MD Anderson Cancer Center (Site 102)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.